As of November 6, 2026, TuHURA Biosciences, Inc./NV is a publicly traded company (Nasdaq: HURA); its largest reported holder is Highbridge, with 9.1% on Schedule 13G of February 17, 2026. The largest insider holding is Vijay Patel, a 10% owner, with 7,999,557 shares (12.6% of shares outstanding) held indirectly (the form names the holder only in its footnotes), per Form 3 of October 22, 2024 (Schedule 13G, February 17, 2026).
Is this your company?
About to sign with, pay or invest in TuHURA Biosciences, Inc./NV? See the free Snapshot first.
Free to see. No signup.
Is TuHURA Biosciences, Inc./NV a real, registered company?
- TuHURA Biosciences, Inc. files with the SEC under CIK 1498382 (its SEC filings).
- Its shares are listed under the ticker HURA on Nasdaq (SEC company record).
- Incorporated in Nevada; business address in Tampa, Florida, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under TuHURA Biosciences, Inc./NV in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Highbridge (filed 2026-02-17).
Who are TuHURA Biosciences, Inc./NV's owners and officers?
TuHURA Biosciences, Inc./NV: incorporated in Nevada; business address in Tampa, Florida; industry Pharmaceutical Preparations (Schedule 13D/A, 2026-08-28).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2025-11-10)
- : Director (Form D, 2025-11-10)
- : Director (Form D, 2025-11-10)
- : Director (Form D, 2025-11-10)
- : Director (Form D, 2025-11-10)
- : Director (Form D, 2025-11-10)
- : Executive Officer (Form D, 2025-11-10)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-08-28 | James A. Bianco, M.D. | 4.6% |
| Schedule 13G, 2026-02-17 | Highbridge Capital Management, LLC | 9.1% |
| Schedule 13G/A, 2025-10-31 | The Vanguard Group | 4.44% |
| Schedule 13G/A, 2025-08-14 | Ca Patel F&F Investments, LLC | 0.9% |
| Schedule 13G/A, 2025-08-14 | Kp Biotech Group LLC | 0.9% |
| Schedule 13G, 2025-07-29 | The Vanguard Group | 5.11% |
Questions about who owns TuHURA Biosciences, Inc./NV
Who owns TuHURA Biosciences, Inc./NV?
On this page, one holder's latest ownership filing reports 5% or more of TuHURA Biosciences, Inc./NV: Highbridge Capital Management, LLC (9.1%, Schedule 13G, filed 2026-02-17).
When did Highbridge Capital Management, LLC buy into TuHURA Biosciences, Inc./NV?
The filings give report dates, not purchase dates. The earliest filing from Highbridge Capital Management, LLC on this page is the Schedule 13G, filed 2026-02-17, reporting 9.1%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on TuHURA Biosciences, Inc./NV?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on TuHURA Biosciences, Inc./NV: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on TuHURA Biosciences, Inc./NV covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own TuHURA Biosciences, Inc./NV shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 7,999,557 shares (12.6% of shares outstanding), held indirectly (the form names the holder only in its footnotes) (Form 3, 2024-10-22).
- , the chief executive and a director: 2,173,307 shares (3.4% of shares outstanding) (Form 4, 2026-05-29).
Shares outstanding: 63,726,617 as of 2026-08-11, from the company's latest SEC cover page.
How much has TuHURA Biosciences, Inc./NV raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-11-10 | $1.50M | $3M |
| Form D, 2025-06-13 | $2.23M | $12.61M |
Latest IPO step: TuHURA Biosciences, Inc./NV amended its IPO registration (S-1/A, 2025-09-18).
IPO filings: S-1/A, 2025-09-18, S-1, 2025-08-12; ticker HURA on Nasdaq Capital Market.
Keep reading
More on TuHURA Biosciences, Inc./NV and the records around it.
TuHURA Biosciences, Inc./NV elsewhere on the record
- 5%+ stake filings Aug 2026
- Form D filing Nov 2025
- Form D filing Jun 2025
Companies that share a holder
- Highbridge Capital Management, LLC also filed stake reports on 83 other companies: Aeon Acquisition I Corp. (Aug 2026), Alpex Acquisition Corp (Aug 2026), Aperture AC (Aug 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/tuhura-biosciences